Literature DB >> 2137690

Molecular organization of heparan sulphate from human skin fibroblasts.

J E Turnbull1, J T Gallagher.   

Abstract

The molecular structure of human skin fibroblast heparan sulphate was examined by specific chemical or enzymic depolymerization and high-resolution separation of the resulting oligosaccharides and disaccharides. Important features of the molecular organization, disaccharide composition and O-sulphate disposition of this heparan sulphate were identified. Analysis of the products of HNO2 hydrolysis revealed a polymer in which 53% of disaccharide units were N-acetylated and 47% N-sulphated, with an N-/O-sulphate ratio of 1.8:1. These two types of disaccharide unit were mainly located in separate domains. Heparitinase and heparinase scission indicated that the iduronate residues (37% of total hexuronate) were largely present in contiguous disaccharide sequences of variable size that also contained the majority of the N-sulphate groups. Most of the iduronate residues (approx. 70%) were non-sulphated. About 8-10% of disaccharide units were cleaved by heparinase, but only a minority of these originated from contiguous sequences in the intact polymer. Trisulphated disaccharide units [alpha-N-sulpho-6-sulphoglucosaminyl-(1----4)-iduronate 2-sulphate], which are the major structural units in heparin, made up only 3% of the disaccharide units in heparan sulphate. O-Sulphate groups (approx. 26 per 100 disaccharide units) were distributed almost evenly among C-6 of N-acetylglucosamine, C-2 of iduronate and C-6 of N-sulphated glucosamine residues. The results indicate that the sulphated regions of heparan sulphate have distinctive and potentially variable structural characteristics. The high content of non-sulphated iduronate in this heparan sulphate species suggests a conformational versatility that could have important implications for the biological properties of the polymer.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2137690      PMCID: PMC1133692          DOI: 10.1042/bj2650715

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  28 in total

1.  The uses of degradative enzymes as tools for identification and structural analysis of glycosaminoglycans.

Authors:  A Linker; P Hovingh
Journal:  Fed Proc       Date:  1977-01

Review 2.  Conformational flexibility: a new concept for explaining binding and biological properties of iduronic acid-containing glycosaminoglycans.

Authors:  B Casu; M Petitou; M Provasoli; P Sinaÿ
Journal:  Trends Biochem Sci       Date:  1988-06       Impact factor: 13.807

3.  Formation of anhydrosugars in the chemical depolymerization of heparin.

Authors:  J E Shively; H E Conrad
Journal:  Biochemistry       Date:  1976-09-07       Impact factor: 3.162

4.  A method for the determination of the molecular weight and molecular-weight distribution of chondroitin sulphate.

Authors:  A Wasteson
Journal:  J Chromatogr       Date:  1971-07-08

5.  Study of structurally defined oligosaccharide substrates of heparin and heparan monosulfate lyases.

Authors:  K G Rice; R J Linhardt
Journal:  Carbohydr Res       Date:  1989-07-15       Impact factor: 2.104

6.  Structural studies on heparan sulphate from human lung fibroblasts. Characterization of oligosaccharides obtained by selective periodate oxidation of D-glucuronic acid residues followed by scission in alkali.

Authors:  I Sjöberg; L A Fransson
Journal:  Biochem J       Date:  1980-10-01       Impact factor: 3.857

7.  Structural characteristics of heparan sulfates with varying sulfate contents.

Authors:  J A Cifonelli; J A King
Journal:  Biochemistry       Date:  1977-05-17       Impact factor: 3.162

8.  The disaccharide composition of heparins and heparan sulfates.

Authors:  Y C Guo; H E Conrad
Journal:  Anal Biochem       Date:  1989-01       Impact factor: 3.365

9.  Undersulfated heparan sulfate in a Chinese hamster ovary cell mutant defective in heparan sulfate N-sulfotransferase.

Authors:  K J Bame; J D Esko
Journal:  J Biol Chem       Date:  1989-05-15       Impact factor: 5.157

10.  Cells selected for high tumorigenicity or transformed by simian virus 40 synthesize heparan sulfate with reduced degree of sulfation.

Authors:  D J Winterbourne; P T Mora
Journal:  J Biol Chem       Date:  1981-05-10       Impact factor: 5.157

View more
  21 in total

1.  Heparin sequencing brings structure to the function of complex oligosaccharides.

Authors:  M A Nugent
Journal:  Proc Natl Acad Sci U S A       Date:  2000-09-12       Impact factor: 11.205

2.  A rapid quantitative assay for the detection of mammalian heparanase activity.

Authors:  C Freeman; C R Parish
Journal:  Biochem J       Date:  1997-07-01       Impact factor: 3.857

3.  Evidence that platelet and tumour heparanases are similar enzymes.

Authors:  C Freeman; A M Browne; C R Parish
Journal:  Biochem J       Date:  1999-09-01       Impact factor: 3.857

4.  Infectivity of Chlamydia trachomatis serovar LGV but not E is dependent on host cell heparan sulfate.

Authors:  M Taraktchoglou; A A Pacey; J E Turnbull; A Eley
Journal:  Infect Immun       Date:  2001-02       Impact factor: 3.441

5.  Specificity and action pattern of heparanase Bp, a β-glucuronidase from Burkholderia pseudomallei.

Authors:  Yanlei Yu; Asher Williams; Xing Zhang; Li Fu; Ke Xia; Yongmei Xu; Fuming Zhang; Jian Liu; Mattheos Koffas; Robert J Linhardt
Journal:  Glycobiology       Date:  2019-07-19       Impact factor: 4.313

6.  Structural domains of heparan sulphate for specific recognition of the C-terminal heparin-binding domain of human plasma fibronectin (HEPII).

Authors:  A Walker; J T Gallagher
Journal:  Biochem J       Date:  1996-08-01       Impact factor: 3.857

7.  Heparan sulfate phage display antibodies identify distinct epitopes with complex binding characteristics: insights into protein binding specificities.

Authors:  Sophie M Thompson; David G Fernig; Edwin C Jesudason; Paul D Losty; Els M A van de Westerlo; Toin H van Kuppevelt; Jeremy E Turnbull
Journal:  J Biol Chem       Date:  2009-12-18       Impact factor: 5.157

8.  Domain structure of endothelial heparan sulphate.

Authors:  A Lindblom; G Bengtsson-Olivecrona; L A Fransson
Journal:  Biochem J       Date:  1991-11-01       Impact factor: 3.857

9.  Accumulation of heparan sulfate in the culture of human melanoma cells with different metastatic ability.

Authors:  M Moczar; F Caux; M Bailly; O Berthier; J F Doré
Journal:  Clin Exp Metastasis       Date:  1993-11       Impact factor: 5.150

10.  Sequence analysis of heparan sulphate indicates defined location of N-sulphated glucosamine and iduronate 2-sulphate residues proximal to the protein-linkage region.

Authors:  J E Turnbull; J T Gallagher
Journal:  Biochem J       Date:  1991-07-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.